Polypharmacy and mortality association by chronic kidney disease status: The <i>RE</i>asons for <i>G</i>eographic <i>A</i>nd <i>R</i>acial <i>D</i>ifferences in <i>S</i>troke Study
Pharmacology research & perspectives